SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-019651
Filing Date
2023-05-31
Accepted
2023-05-31 16:30:49
Documents
12
Period of Report
2023-05-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35142
  Complete submission text file 0001493152-23-019651.txt   204472

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE inti-20230531.xsd EX-101.SCH 3236
3 XBRL LABEL FILE inti-20230531_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE inti-20230531_pre.xml EX-101.PRE 22365
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3286
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13467 | Film No.: 23981409
SIC: 2834 Pharmaceutical Preparations